The management of COPD includes pharmacologic therapy, which may employ new drug categories and new drugs of old categories, but also many nonpharmacologic strategies (pulmonary rehabilitation [PR ...
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
Despite the effectiveness of current pharmacologic therapies ... disease-modifying therapy for the treatment of patients with COPD. Beyond the absence of curative therapy, current treatment ...
In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.
The heritage of Boehringer Ingelheim in developing medicines for respiratory diseases spans almost 100 years. Within the respiratory disease area, innovative treatments for chronic obstructive ...
Researchers from the European Molecular Biology Laboratory have found that dextromethorphan, a common cough syrup ingredient, can potentially treat pu ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback